A Study Of PF-04449913 In Select Hematologic Malignancies

Clinical trial NCT00953758 · COMPLETED

Trial details

NCT number: NCT00953758
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2010-03-03
Primary completion: 2012-09-26
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.